15.1 C
New York
Monday, May 10, 2021
- Advertisement -



Bristol Myers [NYSE: BMY] and Bluebird’s Abecma Receives FDA Approval

Bristol Myers Squibb and Bluebird Bio, Inc. disclosed that their Abecma has got the authorization of the US FDA. FDA has accepted...

Bristol-Myers Squibb’s [NYSE: BMY] Breyanzi Receives FDA Approval

Bristol-Myers Squibb declared that FDA has awarded permission to the Breyanzi of the firm for the therapy of adult sufferers with relapsed or...

Latest news

- Advertisement -